Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1532 of 6351
-
New scan could spare men unnecessary biopsies
Diagnosis Recruiting nowThe goal of this clinical study is to test the performance of PSMA PET/MRI-guided biopsies against systematic biopsies in men with negative MRI scan (PI-RADS 1-2) of the prostate with continuous suspicion of clinically significant prostate cancer (csPCa) due to PSAd \> 0.20. The …
Sponsor: Mads Ryo Jochumsen • Aim: Diagnosis
Last updated Jun 27, 2026 08:01 UTC
-
New combo pill aims to boost cystic fibrosis treatment
Disease control OngoingThe purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of SION-719 when given to people with CF who are already taking Trikafta.
Phase 2 • Sponsor: Sionna Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a few drops of milk boost preemie brain and feeding?
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if the multisensory early oral administration of human milk (M-MILK) intervention helps infants who are born younger than 32 weeks gestational age (very preterm infants). The main question that this clinical trial aims to answer is: Doe…
Sponsor: Loyola University • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Feeding or fasting? study probes transfusion risks in tiny preemies
Knowledge-focused Recruiting nowMAGPIE-2 is a prospective observational study designed to investigate the physiological mechanisms linking blood transfusion and enteral feeding practices to gut perfusion and oxygenation in very preterm infants. The study is nested within the WHEAT International randomised contr…
Sponsor: Imperial College Healthcare NHS Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
New drug shows promise for dangerous virus in blood cancer patients
Disease control Recruiting nowThis is an open-label, single arm, multicenter study to evaluate the feasibility of maribavir treatment in multiple myeloma and lymphoma patients undergoing bispecific antibody treatment and experiencing treatment emergent CMV events
Phase 2 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Exercise program aims to fight 'Chemo Brain' in Long-Term survivors
Disease control Not yet recruitingStudy Rationale: Breast cancer survivors are more likely to develop cardiovascular disease (CVD) or neurocognitive disease than age-matched counterparts without a history of cancer diagnosis. Some anti-cancer treatments cause damage to the cells of heart and the walls of blood v…
Sponsor: Baker Heart and Diabetes Institute • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New hope for Still's disease: experimental drug enters Mid-Stage trial
Disease control Recruiting nowThe study is a phase II trial designed to evaluate the clinical efficacy, safety, and tolerability of MAS825 (arumakimig) in pediatric and adult participants with Still's disease
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 10, 2026 06:00 UTC
-
New nasal COVID vaccine could replace shots
Vaccine OngoingA Double-blind, Randomized, Controlled, Phase 2a Study to Evaluate the Safety and Tolerability of a Newcastle Disease Virus-based Mucosal Vaccine (NDV-HXP-S-KP.2) Relative to an Approved Systemic mRNA Vaccine in Previously Vaccinated Adults
Phase 2 • Sponsor: CastleVax Inc. • Aim: Vaccine
Last updated Jul 24, 2026 00:00 UTC
-
CBD boosts talk therapy for anxiety? new trial investigates
Symptom relief Recruiting nowThis randomized, double-blind, placebo-controlled clinical trial investigates the use of Food and Drug Administration (FDA)-approved cannabidiol (EPIDIOLEX®) as an adjunct to cognitive behavioral therapy (CBT) in adults with generalized anxiety disorder (GAD). The study aims to e…
Phase 3 • Sponsor: Wayne State University • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
New pain drug could cut opioid use after hip surgery
Symptom relief Recruiting nowTotal hip and knee joint replacements are among the most common and painful orthopedic procedures performed worldwide, often requiring intensive analgesia to support early ambulation and recovery. Despite widespread use of multimodal regimens, many patients still rely on opioids,…
Phase 3 • Sponsor: Hospital for Special Surgery, New York • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC
-
Engineered immune cells target stubborn abdominal cancer
Disease control Recruiting nowThis single-arm, open-label, dose-escalation trial aims to evaluate the safety and efficacy of CEA-targeted CAR-T cells and to obtain their pharmacokinetic profile in patients with advanced colorectal cancer and peritoneal metastases after cytoreductive surgery; the recommended d…
Phase 1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could an extra nerve block double the pain relief after hip surgery?
Symptom relief CompletedThe aim of the Study is to compare the analgesic efficacy and clinical outcomes of suprainguinal fascia iliaca block (SIFIB) alone versus SIFIB combined with sciatic nerve block (SNB) in patients undergoing hip surgery.
Phase 1 • Sponsor: Ain Shams University • Aim: Symptom relief
Last updated Aug 28, 2026 00:00 UTC
-
Texts and calls could be key to beating high blood pressure in nepal
Disease control Recruiting nowDespite evidence of preventing cardiovascular disease (CVD) risk through lifestyle changes, many patients with hypertension (HTN) do not comply with this and suffer from CVD and other complications. A previous study using a structured lifestyle intervention program has reported a…
Sponsor: Central Department of Public Health • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Could a milk protein help dialysis patients fight anemia?
Disease control OngoingThe aim of this interventional study is to assess the effectiveness of oral lactoferrin in improving hemoglobin levels and correcting iron deficiency anemia in patients with end-stage renal disease (ESRD) on dialysis and also evaluate the impact of lactoferrin on bone health by m…
Phase 2 • Sponsor: Beni-Suef University • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Breathing trainer may delay ventilator need in ALS patients
Disease control Recruiting nowThe goal of this clinical trial is to determine whether lung insufflation capacity (LIC) training can help maintain respiratory function and prolong tracheostomy-free survival in people with amyotrophic lateral sclerosis (ALS). The main questions are: Does early and continuous …
Sponsor: National Center of Neurology and Psychiatry, Japan • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New liquid embolic shows promise for prostate troubles
Disease control Not yet recruitingProstatic Artery Embolization (PAE) is a recognized mini-invasive treatment of bothersome Lower Urinary Tract Symptoms (LUTS) related to Benign Prostatic Hyperplasia (BPH). Particle embolics are used almost exclusively for embolization, with wide variation in the type and size of…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Could a drug calm this rare muscle and lung disease?
Disease control Recruiting nowThe goal of this clinical trial is to learn if tocilizumab works to treat anti-MDA5+ dermatomyositis (anti-MDA5+DM) in adults. It will also learn about the safety of tocilizumab. The main questions it aims to answer are: Does tocilizumab improve patients' clinical symptoms? Does…
Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New AI tool could revolutionize male fertility testing for IVF
Diagnosis Not yet recruitingInfertility is a growing global health problem affecting millions of couples worldwide, with male infertility accounting for approximately half of all cases. In the physiological environment, sperm go through an exhaustive selection process in the female reproductive tract before…
Sponsor: Instituto Valenciano de Infertilidad, IVI VALENCIA • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
New drug cocktail aims to tame deadly immune storm in lymphoma
Disease control Recruiting nowFor patients who met the inclusion criteria, treatment regimens were administered: Rituximab 375 mg/m², intravenously, once weekly for 4 weeks. Zanubrutinib 160 mg, orally, twice daily for 4 weeks. Combined drugs: prednisone 100 mg/m²/d, orally, d1-5; Ruxolitinib 15mg bid orally…
Phase 4 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New program aims to help seniors recover after ICU stays
Disease control Not yet recruitingIMPROVE-65 is a randomised control trial designed specifically for people aged over 65 who have survived critical illness. It aims to support patients and general practitioners by providing timely, personalised information to help them work together to make informed goals and dec…
Phase 3 • Sponsor: Australian and New Zealand Intensive Care Research Centre • Aim: Disease control
Last updated Jun 26, 2026 19:00 UTC